Greenup Street Wealth Management’s AbbVie ABBV Stock Holding History

Greenup Street Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1M	Buy	3,980 +31	+0.8%	+$6.67K	0.12%	71
2026 Q1	$859K	Buy	3,949 +128	+3%	+$28.4K	0.12%	74
2025 Q4	$873K	Buy	3,821 +120	+3%	+$27.3K	0.13%	69
2025 Q3	$857K	Buy	3,701 +2,054	+125%	+$418K	0.13%	81
2025 Q2	$306K	Buy	1,647 +118	+8%	+$21.9K	0.05%	85
2025 Q1	$320K	Buy	1,529 +37	+2%	+$7.19K	0.06%	82
2024 Q4	$265K	Buy	1,492 +42	+3%	+$7.72K	0.05%	86
2024 Q3	$286K	Buy	1,450 +13	+0.9%	+$2.43K	0.06%	76
2024 Q2	$246K	Buy	1,437 +8	+0.6%	+$1.32K	0.06%	77
2024 Q1	$260K	Sell	1,429 -61	-4%	-$10.5K	0.07%	74
2023 Q4	$231K	Buy	+1,490	New	+$217K	0.06%	74

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Greenup Street Wealth Management's ABBV Position: Q2 2026 in Review

Greenup Street Wealth Management increased its AbbVie (ABBV) stake by 0.79% in Q2 2026, buying an estimated $6.67K and bringing the position to 3,980 shares worth $1M. The position accounts for 0.12% of the portfolio, ranked #71.

Greenup Street Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Greenup Street Wealth Management held 3,980 shares of AbbVie worth $1M as of Q2 2026.
Greenup Street Wealth Management bought 31 AbbVie shares in Q2 2026, an estimated $6.67K.
AbbVie made up 0.12% of Greenup Street Wealth Management's portfolio in Q2 2026, its #71 holding.
Greenup Street Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Greenup Street Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.